5-Amino-1MQ
Small-molecule NNMT inhibitor for adipose and metabolic research
5 mg vial · 50 mg vialpeptide · also known as AOD9604 parent fragment
The C-terminal fragment of human growth hormone studied in lipid metabolism.
HGH Fragment 176-191 · 5 mg · Lyophilised vial
peptide · also known as AOD9604 parent fragment
The C-terminal fragment of human growth hormone studied in lipid metabolism.
In stock
HGH Fragment 176-191 is a synthetic peptide corresponding to amino acids 176 to 191 of human growth hormone, the region associated with the hormone's effect on fat metabolism. It is the parent fragment from which AOD-9604 was derived.
PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.
| Compound | HGH Fragment 176-191 (AOD9604 parent fragment) |
|---|---|
| Type | Peptide |
| Selected presentation | 5 mg · Lyophilised vial |
| Form | Lyophilised powder in a sealed glass vial |
| Fill volume and concentration | Not applicable (lyophilised) |
| Label | CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only" |
| Storage | -20 °C for long-term storage; 2 to 8 °C for under three months; away from light |
| Certificate of analysis | Not yet published online. Request for a batch |
| Research areas | Metabolic & GLP research |
| All presentations | 5 mg lyophilised vial · € 25.00 |